Document text
Principal Investigator: Jordi Ochando
Organization: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Fiscal Year: 2019
Award: $170,390
Funding agency: National Cancer Institute
ABSTRACT – FLOW CYTOMETRY SHARED RESOURCE
Shared Resource Leader: Jordi Ochando, PhD
The Tisch Cancer Institute (TCI) Flow Cytometry Shared Resource Facility (FCSRF) provides TCI members
access to state-of-the-art technology and expertise for the successful development of scientific research
projects. Flow cytometry is a powerful technology that enables researchers to study simultaneous
multiparametric characteristics of thousands of cells per second to decipher complex cellular and molecular
processes in health and disease. The FCSRF offers services for routine applications such as single cell
isolation to rapidly isolate live cells conduct more innovative and complex biological studies such as RNAseq,
metabolomics, and lipidomics assays. The FCSRF is comprised of the institutional Flow Cytometry Shared
Resource Facility and two TCI satellite sites. The FCSRF is equipped with 4 analyzers, 2 mouse cell sorters, 3
cell sorters contained in biosafety level 2+ areas dedicated to isolate non-fixed human samples and mouse
cells infected with class II pathogens, and 1 mass cytometer (CyTOF). In addition, two satellite sites are
equipped with 4 analyzers. Staffed with 7 flow and mass cytometry specialists committed at 100% to this
facility, the SRF provides operational, training, and consultation services covering all aspects of flow cytometry
including cell cycle analysis, isolation single cells from cancer patients, and identification of over 30 different
cell surface/intracellular antigens on the same cell using mass cytometry. With this in mind, our mission is to
provide the necessary instrumentation and knowledge regarding flow/mass cytometry and cell sorting so that
Tisch Cancer Institute investigators improve human cancer diagnosis and treatment through basic sciences,
translational, and clinical research.
Terms: <ATGN><Antigens><Area><Assay><Basic Research><Basic Science><Bioassay><Biologic Assays><Biological><Biological Assay><CCSG><Cancer Center Support Grant><Cancer Patient><Cancer Treatment><Cancers><Cell Body><Cell Cycle><Cell Division Cycle><Cell Isolation><Cell Segregation><Cell Separation><Cell Separation Technology><Cell surface><Cells><Characteristics><Clinical Research><Clinical Study><Complex><Consultations><Cytometry><Development><Disease><Disorder><Doctor of Philosophy><Ensure><Equipment><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Cytometry Shared Resource><Flow Microfluorimetry><Flow Microfluorometry><Goals><Health><Human><Institutes><Investigators><Knowledge><Laboratories><Malignant Cell><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Methods><Mice><Mice Mammals><Mind><Mission><Modern Man><Molecular><Murine><Mus><Personnel Recruitments><Ph.D.><PhD><Process><Productivity><R-Series Research Projects><R01 Mechanism><R01 Program><RNA Seq><RNA sequencing><RNAseq><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Sampling><Services><Site><Specialist><Technology><Training><Translational Research><Translational Science><anti-cancer research><anti-cancer therapy><anticancer research><anticancer therapy><cancer cell><cancer diagnosis><cancer research><cancer therapy><cell sorting><clinical investigation><cost effectiveness><developmental><experiment><experimental research><experimental study><flow cytophotometry><immunogen><improved><innovate><innovation><innovative><instrumentation><malignancy><meetings><member><metabolism measurement><metabolomics><metabonomics><neoplasm/cancer><new technology><novel technologies><pathogen><transcriptome sequencing><translation research>